BUZZ-Australia's Memphasys surges on regulatory nod for reproductive technology
Reuters
Feb 09
BUZZ-Australia's <a href="https://laohu8.com/S/MEM.AU">Memphasys</a> surges on regulatory nod for reproductive technology
** Shares of Memphasys MEM.AX rise as much as 33.3% to A$0.008 in early trade, hitting their highest since February 3
** Stock logs largest intraday pct gain since February 2
** Assisted reproductive tech firm secures regulatory approval from Australia's Therapeutic Goods Association for its Felix tech system
** Felix is a bioseparation system that isolates the most viable sperm cells for human-assisted reproduction
** More than 16 million shares change hands, 2 times the 30-day average volume
** Stock flat YTD, including the day's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.